Cargando…
Inhibition of Macrophage-Specific CHIT1 as an Approach to Treat Airway Remodeling in Severe Asthma
Chitotriosidase (CHIT1) is an enzyme produced by macrophages that regulates their differentiation and polarization. Lung macrophages have been implicated in asthma development; therefore, we asked whether pharmacological inhibition of macrophage-specific CHIT1 would have beneficial effects in asthma...
Autores principales: | Sklepkiewicz, Piotr, Dymek, Barbara, Mlacki, Michal, Zagozdzon, Agnieszka, Salamon, Magdalena, Siwińska, Anna Maria, Mazurkiewicz, Marcin Piotr, de Souza Xavier Costa, Natalia, Mazur, Marzena, Mauad, Thais, Gołębiowski, Adam, Dzwonek, Karolina, Gołąb, Jakub, Zasłona, Zbigniew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10003607/ https://www.ncbi.nlm.nih.gov/pubmed/36902148 http://dx.doi.org/10.3390/ijms24054719 |
Ejemplares similares
-
Pharmacological Inhibition of Chitotriosidase (CHIT1) as a Novel Therapeutic Approach for Sarcoidosis
por: Dymek, Barbara, et al.
Publicado: (2022) -
OATD-02 Validates the Benefits of Pharmacological Inhibition of Arginase 1 and 2 in Cancer
por: Grzybowski, Marcin Mikołaj, et al.
Publicado: (2022) -
Chit-Chat
Publicado: (1873) -
Chit-Chat
Publicado: (1873) -
Chit-Chat
Publicado: (1874)